Andrew O'Connor

Andrew O'Connor is a dedicated engineer and technical leader currently pursuing dual Master’s degrees in Business Administration and Engineering Sciences at Harvard. With a background in process development engineering and roles such as COO at Alveolus Bio and ResBiotic, Andrew has demonstrated a commitment to advancing health and technology. They are currently an investment professional at Morningside Technology Advisory LLC and a board observer for several innovative companies. Their past experience includes a VC summer associate position at In-Q-Tel and advisory roles at Xfund, showcasing a strong interest in early-stage technology investments.